AMS Technologies Announces Availability of HyBoard Hybrid PIC Platform Throughout Europe

CIP Technologies (CIP) has officially launched the HyBoard(TM) hybrid Photonic Integrated Circuit (PIC) platform, which is available from AMS Technologies throughout Europe.

The hybrid integration platform enables systems integrators to offer high performance, highly functional, custom PICs at telecoms production volumes and competitive cost points. The platform provides assembly and form factor advantages over traditional multiple gold box solutions, and delivers a degree of flexibility, performance and functionality that is not possible with full monolithic integration.

CIP demonstrated at ECOC 2008 a proof-of-concept multichannel DWDM laser module producing 16 independent wavelengths on a 50GHz grid. This prototype multi-wavelength laser source incorporates multiple indium phosphide (InP) optoelectronic device arrays aligned to silica planar waveguides and other passive optical elements, including an AWG located on the optical motherboard. The 16 lasers within the multi-wavelength source can each provide >0dBm output power and are individually addressable to enable channel power control and switching. This particular module, aimed at WDM-PON headends and metro WDM, is one variant of the range of compact, cost-effective hybrid integrated designs now available to systems integrators that can be realised with HyBoard.

HyBoard can be extended to accommodate optical isolators, thin film filters and polarization elements, as well as customisable channel spacings and a wide range of different active/passive component arrays, including tunables.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.